Can Mild Pressure Actually Change What's Happening Inside Your Body?
A 2023 study published in Frontiers in Neurology found that mild hyperbaric air exposure — at a pressure level similar to the 1.3 ATA environment the O2 Box is built around — was associated with measurable changes in the body's natural cellular activity in healthy adults over just 10 sessions.
That's a big deal — and it's worth understanding why, especially if you're exploring mHBOT for your wellness space or your own personal routine.
What the Research Found
The study, conducted by MacLaughlin, Barton, Braun, and colleagues at the University of Wisconsin–Madison and the University of Texas Southwestern Medical Center, looked at what happened to healthy adults who completed 10 hyperbaric air sessions over two weeks.
Each session lasted 90 minutes at approximately 1.27 ATA — a mild hyperbaric pressure level in the same range as the 1.3 ATA environment O2 Box is designed around.
Here's what researchers observed:
By the 10th session, the body showed roughly twice the level of natural cellular activity compared to the start
Three days after the final session, that elevated cellular activity was still three times higher than baseline — suggesting the effects weren't just temporary
Researchers also observed changes in markers the body uses to regulate its own internal processes
In plain terms: after just 10 sessions at mild hyperbaric pressure, the body wasn't just sitting quietly inside the chamber. It was responding.
Why This Is Significant for mHBOT
For years, the assumption in hyperbaric research was that meaningful physiological responses required high pressure — 2.0 ATA or greater — combined with pure oxygen. This study challenged that assumption.
Researchers found that mild hyperbaric air alone — no supplemental oxygen required — was enough to produce measurable changes in healthy human subjects. That places mild hyperbaric therapy in a new category of research interest, and it supports the growing wellness conversation around mHBOT at 1.3 ATA.
This also matters for how O2 Box is positioned: as a wellness tool that operates at mild, comfortable pressure without requiring the clinical infrastructure of traditional high-pressure chambers.
How This Connects to O2 Box
O2 Box operates at 1.3 ATA — essentially the same mild hyperbaric range explored in this research. Sessions are 60 minutes, and clients can choose to breathe room air, use a nasal cannula, or wear a mask depending on their goals and their provider's setup.
This study doesn't tell us exactly what will happen for any individual O2 Box user — individual results always vary, and O2 Box is not a medical device. But it does add meaningful, peer-reviewed context to why people in wellness, recovery, and performance spaces are paying attention to mild hyperbaric therapy.
The body responds to environment. Creating a higher-oxygen, mildly pressurized environment for 60 minutes is at the core of what O2 Box does — and the science around that environment continues to grow.
What This Means for Your Clients
If you're a wellness provider considering O2 Box, this kind of research is worth having in your back pocket — not to make medical claims, but to help clients understand that mHBOT is an area of active, credible scientific interest.
When clients ask "has this been studied?" — the answer is yes.
University researchers. Peer-reviewed journals. Measurable results at mild pressure. That's the foundation O2 Box sessions are built on.
Want to Learn More About Bringing O2 Box Into Your Space?
Whether you're a chiropractor, med spa, gym, or wellness center, we'd love to walk you through how mHBOT fits into what you're already doing for your clients. Schedule a private demo with our team and get your questions answered.
Study Reference
MacLaughlin KJ, Barton GP, Braun RK, MacLaughlin JE, Lamers JJ, Marcou MD, Eldridge MW. Hyperbaric air mobilizes stem cells in humans; a new perspective on the hormetic dose curve. Front. Neurol. 2023;14:1192793. Published June 20, 2023.
Affiliations: University of Wisconsin–Madison (Department of Pediatrics) & University of Texas Southwestern Medical Center (Department of Internal Medicine).
Read the full study in Frontiers in Neurology or on PubMed.